{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T07:33:18Z","timestamp":1773559998994,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["107TMU-WFH-07"],"award-info":[{"award-number":["107TMU-WFH-07"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022600","name":"Wan Fang Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022600","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.amjms.2022.01.026","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T19:56:41Z","timestamp":1650916601000},"page":"575-582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Relationship between metformin use and lactic acidosis in advanced chronic kidney disease: The REMIND-TMU study"],"prefix":"10.1016","volume":"364","author":[{"given":"Chien-Chou","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Jen","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-En","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-Hao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sih-Shan","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken N.","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiehfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.amjms.2022.01.026_bib0001","first-page":"S98","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2020","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.amjms.2022.01.026_bib0002","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1001\/archinternmed.2009.20","article-title":"Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus","volume":"169","author":"Kooy","year":"2009","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.amjms.2022.01.026_bib0003","doi-asserted-by":"crossref","first-page":"740","DOI":"10.7326\/M15-2650","article-title":"Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis","volume":"164","author":"Maruthur","year":"2016","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.amjms.2022.01.026_bib0004","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12933-019-0900-7","article-title":"Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis","volume":"18","author":"Han","year":"2019","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10.1016\/j.amjms.2022.01.026_bib0005","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2337\/dc17-2231","article-title":"Metformin treatment in patients with type 2 diabetes and chronic kidney disease stages 3A, 3B, or 4","volume":"41","author":"Lalau","year":"2018","journal-title":"Diabetes care"},{"issue":"7","key":"10.1016\/j.amjms.2022.01.026_bib0006","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/jamainternmed.2018.0292","article-title":"Association of metformin use with risk of lactic acidosis across the range of kidney function: a community-based cohort study","volume":"178","author":"Lazarus","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"8","key":"10.1016\/j.amjms.2022.01.026_bib0007","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.2337\/dc13-3023","article-title":"Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study","volume":"37","author":"Eppenga","year":"2014","journal-title":"Diabetes care"},{"key":"10.1016\/j.amjms.2022.01.026_bib0008","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/2050-6511-14-22","article-title":"The prognostic value of blood pH and lactate and metformin concentrations in severe metformin-associated lactic acidosis","volume":"14","author":"Kajbaf","year":"2013","journal-title":"BMC pharmacol amp; toxicol"},{"issue":"8","key":"10.1016\/j.amjms.2022.01.026_bib0009","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2337\/dc14-0464","article-title":"Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort study","volume":"37","author":"Richy","year":"2014","journal-title":"Diabetes care"},{"issue":"9","key":"10.1016\/j.amjms.2022.01.026_bib0010","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2165\/11536790-000000000-00000","article-title":"Lactic acidosis induced by metformin: incidence, management and prevention","volume":"33","author":"Lalau","year":"2010","journal-title":"Drug Saf"},{"issue":"9","key":"10.1016\/j.amjms.2022.01.026_bib0011","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199602293340906","article-title":"Metformin","volume":"334","author":"Bailey","year":"1996","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.amjms.2022.01.026_bib0012","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/sj.ki.5000377","article-title":"Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective","volume":"69","author":"Parving","year":"2006","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.amjms.2022.01.026_bib0013","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/dom.12658","article-title":"Secular trends in antihyperglycaemic medication prescriptions in older adults with diabetes and chronic kidney disease: 2004-2013","volume":"18","author":"Clemens","year":"2016","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.amjms.2022.01.026_bib0014","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ki.2014.19","article-title":"Metformin and other antidiabetic agents in renal failure patients","volume":"87","author":"Lalau","year":"2015","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.amjms.2022.01.026_bib0015","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1111\/dom.12974","article-title":"Metformin-associated lactic acidosis (MALA): Moving towards a new paradigm","volume":"19","author":"Lalau","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1016\/j.amjms.2022.01.026_bib0016","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.amjms.2022.01.026_bib0017","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2478\/jtim-2018-0005","article-title":"Do Statins Induce or Protect from Acute Kidney Injury and Chronic Kidney Disease: An Update Review in 2018","volume":"6","author":"Verdoodt","year":"2018","journal-title":"J transl int med"},{"issue":"23","key":"10.1016\/j.amjms.2022.01.026_bib0018","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/j.jacc.2019.09.059","article-title":"Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure","volume":"74","author":"Kotecha","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.amjms.2022.01.026_bib0019","first-page":"1008","article-title":"Non-selective beta-blocker treatment does not impact on kidney function in cirrhotic patients with varices","volume":"52","author":"Scheiner","year":"2017","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.amjms.2022.01.026_bib0020","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s13054-018-2097-7","article-title":"Loop diuretic use in patients with AKI: different severity, different response","volume":"22","author":"Shen","year":"2018","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.amjms.2022.01.026_bib0021","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jash.2012.07.004","article-title":"Thiazide diuretics in advanced chronic kidney disease","volume":"6","author":"Agarwal","year":"2012","journal-title":"J Am Soc Hypertens"},{"issue":"10","key":"10.1016\/j.amjms.2022.01.026_bib0022","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/jgs.14253","article-title":"Use and interpretation of propensity scores in aging research: a guide for clinical researchers","volume":"64","author":"Kim","year":"2016","journal-title":"J Am Geriatr Soc"},{"issue":"20","key":"10.1016\/j.amjms.2022.01.026_bib0023","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/sim.3854","article-title":"The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studies","volume":"29","author":"Austin","year":"2010","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.amjms.2022.01.026_bib0024","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"issue":"6","key":"10.1016\/j.amjms.2022.01.026_bib0025","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat - Simul Comput"},{"issue":"3","key":"10.1016\/j.amjms.2022.01.026_bib0026","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/00031305.1986.10475403","article-title":"Standard distance in univariate and multivariate analysis","volume":"40","author":"Flury","year":"1986","journal-title":"Am Stat"},{"issue":"8","key":"10.1016\/j.amjms.2022.01.026_bib0027","doi-asserted-by":"crossref","first-page":"e23200","DOI":"10.1371\/journal.pone.0023200","article-title":"Management of metformin-associated lactic acidosis by continuous renal replacement therapy","volume":"6","author":"Keller","year":"2011","journal-title":"PloS one"},{"issue":"4","key":"10.1016\/j.amjms.2022.01.026_bib0028","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/ajcp\/80.4.484","article-title":"Definition of clinically relevant lactic acidosis in patients with internal diseases","volume":"80","author":"Luft","year":"1983","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.amjms.2022.01.026_bib0029","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2337\/diacare.22.6.925","article-title":"Incidence of lactic acidosis in metformin users","volume":"22","author":"Stang","year":"1999","journal-title":"Diabetes care"},{"issue":"6","key":"10.1016\/j.amjms.2022.01.026_bib0030","doi-asserted-by":"crossref","first-page":"R226","DOI":"10.1186\/cc9376","article-title":"Outcome of severe lactic acidosis associated with metformin accumulation","volume":"14","author":"Friesecke","year":"2010","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.amjms.2022.01.026_bib0031","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/dme.12017","article-title":"The criteria for metformin-associated lactic acidosis: the quality of reporting in a large pharmacovigilance database","volume":"30","author":"Kajbaf","year":"2013","journal-title":"Diabet Med"},{"issue":"8","key":"10.1016\/j.amjms.2022.01.026_bib0032","first-page":"792","article-title":"Lactic acidosis in medical ICU - the role of diabetes mellitus and metformin","volume":"33","author":"Hloch","year":"2012","journal-title":"Neuro Endocrinol Lett"},{"issue":"3","key":"10.1016\/j.amjms.2022.01.026_bib0033","doi-asserted-by":"crossref","first-page":"91","DOI":"10.20452\/pamw.1619","article-title":"Lactic acidosis in patients with diabetes","volume":"123","author":"Krzymie\u0144","year":"2013","journal-title":"Pol Arch Med Wewn"},{"issue":"8","key":"10.1016\/j.amjms.2022.01.026_bib0034","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S2213-8587(15)00123-0","article-title":"Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study","volume":"3","author":"Hung","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.amjms.2022.01.026_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8010100","article-title":"Adverse outcomes after major surgeries in patients with diabetes: a multicenter matched study","volume":"8","author":"Lin","year":"2019","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.amjms.2022.01.026_bib0036","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/jcsm.12423","article-title":"Effect of weight loss on the estimated glomerular filtration rates of obese patients at risk of chronic kidney disease: the RIGOR-TMU study","volume":"10","author":"Lin","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.amjms.2022.01.026_bib0037","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/ki.2014.110","article-title":"An instrumental variable approach finds no associated harm or benefit with early dialysis initiation in the United States","volume":"86","author":"Scialla","year":"2014","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.amjms.2022.01.026_bib0038","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1111\/bcp.14107","article-title":"Is the use of metformin in patients undergoing dialysis hazardous for life? A systematic review of the safety of metformin in patients undergoing dialysis","volume":"85","author":"Abdel Shaheed","year":"2019","journal-title":"Br J Clin Pharmacol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962922001665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962922001665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:16:08Z","timestamp":1762082168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962922001665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0002962922001665"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2022.01.026","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between metformin use and lactic acidosis in advanced chronic kidney disease: The REMIND-TMU study","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2022.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of Southern Society for Clinical Investigation.","name":"copyright","label":"Copyright"}]}}